ERGEA HEALTHCARE LEEDS AND BELFAST LIMITEDActive

Company number 08266811Private limited companyIncorporated 2012

Key figures

£322,822-1.6%
Net assets 2023
-1.8%
Average annual change 2021–2023
0100 k200 k300 k400 k202120222023

Like most small UK companies, ERGEA HEALTHCARE LEEDS AND BELFAST LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m202120222023
Filed accounts2021–2023
202120222023
Total assets———
Total liabilities7,609,9927,617,6757,622,204
Net assets / total equity335,034328,122322,822
Average number of employees333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2023

The principal activity of the company is that of an intermediate holding company for businesses providing services relating to medical equipment to public sector hospitals in the United Kingdom.

As described in the company's latest filed accounts.

Summary: ERGEA HEALTHCARE LEEDS AND BELFAST LIMITED

Company

ERGEA HEALTHCARE LEEDS AND BELFAST LIMITED is a private limited company registered with Companies House under company number 08266811. It was incorporated on 24 Oct 2012. Its status is active. The registered office is in Reading (RG7). Its nature of business (SIC 2007) is hospital activities (86101).

Accounts

The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files full accounts. Net assets were £322,822, down 1.6% on the previous year. The company had an average of 3 employees. Figures are available for 3 financial years (2021–2023).

Control and charges

One person with significant control is registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 Nov 2026.